307 related articles for article (PubMed ID: 34914188)
21. Pyridine and Pyrimidine Derivatives as Privileged Scaffolds in Biologically Active Agents.
Chiacchio MA; Iannazzo D; Romeo R; Giofrè SV; Legnani L
Curr Med Chem; 2019; 26(40):7166-7195. PubMed ID: 30182842
[TBL] [Abstract][Full Text] [Related]
22. Recent advances in the chemistry and biology of pyridopyrimidines.
Buron F; Mérour JY; Akssira M; Guillaumet G; Routier S
Eur J Med Chem; 2015 May; 95():76-95. PubMed ID: 25794791
[TBL] [Abstract][Full Text] [Related]
23. Roles of Pyridine and Pyrimidine Derivatives as Privileged Scaffolds in Anticancer Agents.
Prachayasittikul S; Pingaew R; Worachartcheewan A; Sinthupoom N; Prachayasittikul V; Ruchirawat S; Prachayasittikul V
Mini Rev Med Chem; 2017; 17(10):869-901. PubMed ID: 27670581
[TBL] [Abstract][Full Text] [Related]
24. Phthalazin-1(2H)-one as a remarkable scaffold in drug discovery.
Vila N; Besada P; Costas T; Costas-Lago MC; Terán C
Eur J Med Chem; 2015 Jun; 97():462-82. PubMed ID: 25482553
[TBL] [Abstract][Full Text] [Related]
25. A review on antioxidant potential of bioactive heterocycle benzofuran: Natural and synthetic derivatives.
Chand K; Rajeshwari ; Hiremathad A; Singh M; Santos MA; Keri RS
Pharmacol Rep; 2017 Apr; 69(2):281-295. PubMed ID: 28171830
[TBL] [Abstract][Full Text] [Related]
26. Heterocyclic pyrimidine derivatives as promising antibacterial agents.
Ahmed K; Choudhary MI; Saleem RSZ
Eur J Med Chem; 2023 Nov; 259():115701. PubMed ID: 37591149
[TBL] [Abstract][Full Text] [Related]
27. Synthetic and Biological Attributes of Pyrimidine Derivatives: A Recent Update.
Devi M; Jaiswal S; Jain S; Kaur N; Dwivedi J
Curr Org Synth; 2021; 18(8):790-825. PubMed ID: 34886770
[TBL] [Abstract][Full Text] [Related]
28. Oxygen- and Sulphur-Containing Heterocyclic Compounds as Potential Anticancer Agents.
Sachdeva H; Khaturia S; Saquib M; Khatik N; Khandelwal AR; Meena R; Sharma K
Appl Biochem Biotechnol; 2022 Dec; 194(12):6438-6467. PubMed ID: 35900713
[TBL] [Abstract][Full Text] [Related]
29. Advancement in chiral heterocycles for the antidiabetic activity.
Gupta T; Rani D; Nainwal LM; Badhwar R
Chirality; 2024 Feb; 36(2):e23637. PubMed ID: 38384150
[TBL] [Abstract][Full Text] [Related]
30. Bridgehead Nitrogen Thiazolo[3,2-a]pyrimidine: A Privileged Structural Framework in Drug Discovery.
Keshari AK; Singh AK; Saha S
Mini Rev Med Chem; 2017; 17(15):1488-1499. PubMed ID: 28215139
[TBL] [Abstract][Full Text] [Related]
31. Heterocycle-thioacetic acid motif: a privileged molecular scaffold with potent, broad-ranging pharmacological activities.
Song Y; Zhan P; Liu X
Curr Pharm Des; 2013; 19(40):7141-54. PubMed ID: 23859548
[TBL] [Abstract][Full Text] [Related]
32. Role of sulphur-heterocycles in medicinal chemistry: An update.
Pathania S; Narang RK; Rawal RK
Eur J Med Chem; 2019 Oct; 180():486-508. PubMed ID: 31330449
[TBL] [Abstract][Full Text] [Related]
33. New advances in synthesis and clinical aspects of pyrazolo[3,4-d]pyrimidine scaffolds.
Abdellatif KRA; Bakr RB
Bioorg Chem; 2018 Aug; 78():341-357. PubMed ID: 29627655
[TBL] [Abstract][Full Text] [Related]
34. Recent advancements in the development of heterocyclic anti-inflammatory agents.
Sharma S; Kumar D; Singh G; Monga V; Kumar B
Eur J Med Chem; 2020 Aug; 200():112438. PubMed ID: 32485533
[TBL] [Abstract][Full Text] [Related]
35. Therapeutic potential of heterocyclic pyrimidine scaffolds.
Kumar S; Narasimhan B
Chem Cent J; 2018 Apr; 12(1):38. PubMed ID: 29619583
[TBL] [Abstract][Full Text] [Related]
36. Medicinal Chemistry of Pyrazolopyrimidine Scaffolds Substituted with Different Heterocyclic Nuclei.
Elgemeie GH; Azzam RA; Zaghary WA; Khedr MA; Elsherif GE
Curr Pharm Des; 2022; 28(41):3374-3403. PubMed ID: 36330628
[TBL] [Abstract][Full Text] [Related]
37. A review on diverse heterocyclic compounds as the privileged scaffolds in antimalarial drug discovery.
Kalaria PN; Karad SC; Raval DK
Eur J Med Chem; 2018 Oct; 158():917-936. PubMed ID: 30261467
[TBL] [Abstract][Full Text] [Related]
38. A Therapeutic Journey of Pyridine-based Heterocyclic Compounds as Potent Anticancer Agents: A Review (From 2017 to 2021).
Alrooqi M; Khan S; Alhumaydhi FA; Asiri SA; Alshamrani M; Mashraqi MM; Alzamami A; Alshahrani AM; Aldahish AA
Anticancer Agents Med Chem; 2022 Aug; 22(15):2775-2787. PubMed ID: 35331100
[TBL] [Abstract][Full Text] [Related]
39. Ecofriendly synthesis of pyrano[2,3-d]pyrimidine derivatives and related heterocycles with anti-inflammatory activities.
AbdEl-Azim MHM; Aziz MA; Mouneir SM; El-Farargy AF; Shehab WS
Arch Pharm (Weinheim); 2020 Sep; 353(9):e2000084. PubMed ID: 32583459
[TBL] [Abstract][Full Text] [Related]
40. An Overview of the Biological Evaluation of Selected Nitrogen-Containing Heterocycle Medicinal Chemistry Compounds.
Ebenezer O; Jordaan MA; Carena G; Bono T; Shapi M; Tuszynski JA
Int J Mol Sci; 2022 Jul; 23(15):. PubMed ID: 35897691
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
